Plectin promotes an aggressive phenotype and represses cytotoxic T cell activity in pancreatic cancer
Cody L. Wolf, Roxanne K. Ruiz, Sokchea Khou, Robert Cornelison, Edward B. Stelow, Karl M. Kowalewski, Matthew J. Lazzara, Amanda Poissonnier, Lisa M. Coussens, Kimberly A. Kelly
This study identifies plectin as a biomarker of aggressive pancreatic cancer, showing it suppresses T cell activity and that targeting it with an antibody enhances anti-tumor immunity.
Frontiers in Immunology · Aug 17, 2026Peer-reviewedCancer Biology